Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
H Blasco, F Patin, CR Andres, P Corcia & PH Gordon. (2016) Amyotrophic Lateral Sclerosis, 2016: existing therapies and the ongoing search for neuroprotection. Expert Opinion on Pharmacotherapy 17:12, pages 1669-1682.
Read now
Read now
H. Blasco, P. Vourc’h, P. F. Pradat, P. H. Gordon, C. R. Andres & P. Corcia. (2016) Further development of biomarkers in amyotrophic lateral sclerosis. Expert Review of Molecular Diagnostics 16:8, pages 853-868.
Read now
Read now
Martin R. Turner, Robert Bowser, Lucie Bruijn, Luc Dupuis, Albert Ludolph, Michael McGrath, Giovanni Manfredi, Nicholas Maragakis, Robert G. Miller, Seth L. Pullman, Seward B. Rutkove, Pamela J. Shaw, Jeremy Shefner & Kenneth H. Fischbeck. (2013) Mechanisms, models and biomarkers in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:sup1, pages 19-32.
Read now
Read now
Peter Bede, Arun L. W. Bokde, Susan Byrne, Marwa Elamin, Andrew J. Fagan & Orla Hardiman. (2012) Spinal cord markers in ALS: Diagnostic and biomarker considerations. Amyotrophic Lateral Sclerosis 13:5, pages 407-415.
Read now
Read now
Markus Otto, Robert Bowser, Martin Turner, James Berry, Johannes Brettschneider, James Connor, Júlia Costa, Merit Cudkowicz, Jonathan Glass, Olaf Jahn, Stefan Lehnert, Andrea Malaspina, Lucilla Parnetti, Axel Petzold, Pamela Shaw, Alexander Sherman, Petra Steinacker, Sigurd Süßmuth, Charlotte Teunissen, Hayrettin Tumani, Anna Wuolikainen & Albert Ludolph. (2012) Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotrophic Lateral Sclerosis 13:1, pages 1-10.
Read now
Read now
Articles from other publishers (39)
Sandeep C Pingle, Feng Lin, Misa S Anekoji, C Pawan K Patro, Souvik Datta, Lawrence D Jones, Santosh Kesari & Shashaanka Ashili. (2023) Exploring the role of cerebrospinal fluid as analyte in neurologic disorders. Future Science OA 9:4.
Crossref
Crossref
Omair Adil & Mohtashim H. Shamsi. (2023) Electrochemical Impedance Immunoassay for ALS-Associated Neurofilament Protein: Matrix Effect on the Immunoplatform. Biosensors 13:2, pages 247.
Crossref
Crossref
Francesca Vignaroli, Angelica Mele, Giacomo Tondo, Veronica De Giorgis, Marcello Manfredi, Cristoforo Comi, Letizia Mazzini & Fabiola De Marchi. (2023) The Need for Biomarkers in the ALS–FTD Spectrum: A Clinical Point of View on the Role of Proteomics. Proteomes 11:1, pages 1.
Crossref
Crossref
Avgustina Danailova, Svetla Todinova, Lidia Gartcheva, Desislava Bogdanova, Elena Zlatareva, Nikolay Kalaydzhiev, Ivan Milanov, Sashka Krumova & Stefka G. Taneva. (2023) Thermodynamic Signatures of Blood Plasma Proteome in Neurodegenerative Pathologies. International Journal of Molecular Sciences 24:1, pages 789.
Crossref
Crossref
Christian Barro & Henrik Zetterberg. (2021) The blood biomarkers puzzle – A review of protein biomarkers in neurodegenerative diseases. Journal of Neuroscience Methods 361, pages 109281.
Crossref
Crossref
Jessica R. Morrice, Michael Kuo & Christopher A. Shaw. 2021. Spectrums of Amyotrophic Lateral Sclerosis. Spectrums of Amyotrophic Lateral Sclerosis
181
199
.
Carine Z. J. Lim, Auginia Natalia, Noah R. Sundah & Huilin Shao. (2020) Biomarker Organization in Circulating Extracellular Vesicles: New Applications in Detecting Neurodegenerative Diseases. Advanced Biosystems 4:12, pages 1900309.
Crossref
Crossref
Giovanna Morello, Salvatore Salomone, Velia D’Agata, Francesca Luisa Conforti & Sebastiano Cavallaro. (2020) From Multi-Omics Approaches to Precision Medicine in Amyotrophic Lateral Sclerosis. Frontiers in Neuroscience 14.
Crossref
Crossref
Katerina Kadena & Panayiotis Vlamos. 2020. GeNeDis 2018. GeNeDis 2018
179
187
.
Débora Lanznaster, Denis Reis de Assis, Philippe Corcia, Pierre-François Pradat & Hélène Blasco. (2018) Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS. Frontiers in Neurology 9.
Crossref
Crossref
Michael S. Bereman, Joshua Beri, Jeffrey R. Enders & Tara Nash. (2018) Machine Learning Reveals Protein Signatures in CSF and Plasma Fluids of Clinical Value for ALS. Scientific Reports 8:1.
Crossref
Crossref
Nakul Katyal & Raghav Govindarajan. (2017) Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement. Frontiers in Neurology 8.
Crossref
Crossref
Andreas Jeromin & Robert Bowser. 2017. Neurodegenerative Diseases. Neurodegenerative Diseases
491
528
.
Jun Yan, Yun Xu, Li Zhang, Hui Zhao, Ling Jin, Wei-Guo Liu, Lei-Hua Weng, Zuo-Han Li & Ling Chen. (2016) Increased Expressions of Plasma Galectin-3 in Patients with Amyotrophic Lateral Sclerosis. Chinese Medical Journal 129:23, pages 2797-2803.
Crossref
Crossref
Emily F. Mendez & Rita Sattler. (2015) Biomarker development for C9orf72 repeat expansion in ALS. Brain Research 1607, pages 26-35.
Crossref
Crossref
Margherita Grasso, Paola Piscopo, Alessio Crestini, Annamaria Confaloni & Michela A. Denti. 2015. Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance. Circulating microRNAs in Disease Diagnostics and their Potential Biological Relevance
151
169
.
Kristin Elf, Ganna Shevchenko, Ingela Nygren, Lars Larsson, Jonas Bergquist, Håkan Askmark & Konstantin Artemenko. (2014) Alterations in muscle proteome of patients diagnosed with amyotrophic lateral sclerosis. Journal of Proteomics 108, pages 55-64.
Crossref
Crossref
Margherita Grasso, Paola Piscopo, Annamaria Confaloni & Michela Denti. (2014) Circulating miRNAs as Biomarkers for Neurodegenerative Disorders. Molecules 19:5, pages 6891-6910.
Crossref
Crossref
Hélène Blasco, Philippe Corcia & Pierre-François Pradat. (2014) L’utilisation de biomarqueurs dans la SLA est-elle d’actualité ?. La Presse Médicale 43:5, pages 569-579.
Crossref
Crossref
Elena Acquadro, Ilaria Caron, Massimo Tortarolo, Enrico M. Bucci, Caterina Bendotti & Davide Corpillo. (2014) Human SOD1-G93A Specific Distribution Evidenced in Murine Brain of a Transgenic Model for Amyotrophic Lateral Sclerosis by MALDI Imaging Mass Spectrometry. Journal of Proteome Research 13:4, pages 1800-1809.
Crossref
Crossref
Laura Robelin & Jose Luis Gonzalez De Aguilar. (2014) Blood Biomarkers for Amyotrophic Lateral Sclerosis: Myth or Reality?. BioMed Research International 2014, pages 1-11.
Crossref
Crossref
Xenia Kobeleva & Susanne Petri. (2013) Barriers to novel therapeutics in amyotrophic lateral sclerosis. Neurodegenerative Disease Management 3:6, pages 525-537.
Crossref
Crossref
Hélène Blasco, Philippe CorciaPaul H Gordon & Pierre-François Pradat. (2013) Biological and neuroimaging biomarkers for amyotrophic lateral sclerosis: 2013 and beyond. Neurodegenerative Disease Management 3:5, pages 427-444.
Crossref
Crossref
Chi-Shin Hwang, Guan-Ting Liu, Margaret Dah-Tsyr Chang, I-Lin Liao & Hao-Teng Chang. (2013) Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis. Neurobiology of Disease 58, pages 13-18.
Crossref
Crossref
Ana C. Calvo, Raquel Manzano, Gabriela Atencia-Cibreiro, Sara Oliván, María J. Muñoz, Pilar Zaragoza, Pilar Cordero-Vázquez, Jesús Esteban-Pérez, Alberto García-Redondo & Rosario Osta. (2012) Genetic Biomarkers for ALS Disease in Transgenic SOD1G93A Mice. PLoS ONE 7:3, pages e32632.
Crossref
Crossref
P.K. Gupta, S. Prabhakar, S. Sharma & A. Anand. (2012) A predictive model for amyotrophic lateral sclerosis (ALS) diagnosis. Journal of the Neurological Sciences 312:1-2, pages 68-72.
Crossref
Crossref
Robert Bowser, Martin R. Turner & Jeremy Shefner. (2011) Biomarkers in amyotrophic lateral sclerosis: opportunities and limitations. Nature Reviews Neurology 7:11, pages 631-638.
Crossref
Crossref
Jeban Ganesalingam, Jiyan An, Christopher E. Shaw, Gerry Shaw, David Lacomis & Robert Bowser. (2011) Combination of neurofilament heavy chain and complement C3 as CSF biomarkers for ALS. Journal of Neurochemistry 117:3, pages 528-537.
Crossref
Crossref
Lisa Staunton, Harald Jockusch & Kay Ohlendieck. (2011) Proteomic analysis of muscle affected by motor neuron degeneration: The wobbler mouse model of amyotrophic lateral sclerosis. Biochemical and Biophysical Research Communications 406:4, pages 595-600.
Crossref
Crossref
Meghan E. Wilson, Imene Boumaza, David Lacomis & Robert Bowser. (2010) Cystatin C: A Candidate Biomarker for Amyotrophic Lateral Sclerosis. PLoS ONE 5:12, pages e15133.
Crossref
Crossref
Henrik Ryberg, Jiyan An, Samuel Darko, Jonathan Llyle Lustgarten, Matt Jaffa, Vanathi Gopalakrishnan, David Lacomis, Merit Cudkowicz & Robert Bowser. (2010) Discovery and verification of amyotrophic lateral sclerosis biomarkers by proteomics. Muscle & Nerve 42:1, pages 104-111.
Crossref
Crossref
Jeban Ganesalingam & Robert Bowser. (2010) The application of biomarkers in clinical trials for motor neuron disease. Biomarkers in Medicine 4:2, pages 281-297.
Crossref
Crossref
Cynthia P.W. Soon, Peter J. Crouch, Bradley J. Turner, Catriona A. McLean, Katrina M. Laughton, Julie D. Atkin, Colin L. Masters, Anthony R. White & Qiao-Xin Li. (2010) Serum matrix metalloproteinase-9 activity is dysregulated with disease progression in the mutant SOD1 transgenic mice. Neuromuscular Disorders 20:4, pages 260-266.
Crossref
Crossref
Minna A. Korolainen, Tuula A. Nyman, Tero Aittokallio & Tuula Pirttilä. (2010) An update on clinical proteomics in Alzheimer’s research. Journal of Neurochemistry 112:6, pages 1386-1414.
Crossref
Crossref
Robert Bowser & David Lacomis. (2009) Applying proteomics to the diagnosis and treatment of ALS and related diseases. Muscle & Nerve 40:5, pages 753-762.
Crossref
Crossref
Anat Shirvan, Ayelet Reshef, Merav Yogev-Falach & Ilan Ziv. (2009) Molecular imaging of neurodegeneration by a novel cross-disease biomarker. Experimental Neurology 219:1, pages 274-283.
Crossref
Crossref
P. Wicks, M. P. Massagli, C. Wolf & J. Heywood. (2009) Measuring function in advanced ALS: validation of ALSFRS-EX extension items. European Journal of Neurology 16:3, pages 353-359.
Crossref
Crossref
P. Paladino, F. Valentino, T. Piccoli, F. Piccoli & V. La Bella. (2009)
Cerebrospinal fluid
tau
protein is not a biological marker in amyotrophic lateral sclerosis
. European Journal of Neurology 16:2, pages 257-261.
Crossref
Crossref
Martin R Turner, Matthew C Kiernan, P Nigel Leigh & Kevin Talbot. (2009) Biomarkers in amyotrophic lateral sclerosis. The Lancet Neurology 8:1, pages 94-109.
Crossref
Crossref